Identification of Novel Glycogen Synthase Kinase-3? Inhibitor through Combined Shape-Based Screening and Molecular Docking Approach | Zendy

Navneet Chauhan | Zendy; Anuradha K. Gajjar | Zendy; Rueban Jacob Anicattu Issac | Zendy; Sravan Kumar Pucha | Zendy; Premkumar Arumugam | Zendy

Open Access

Identification of Novel Glycogen Synthase Kinase-3? Inhibitor through Combined Shape-Based Screening and Molecular Docking Approach

Author(s) -

Navneet Chauhan,

Anuradha K. Gajjar,

Rueban Jacob Anicattu Issac,

Sravan Kumar Pucha,

Premkumar Arumugam

Publication year - 2017

Publication title -

international journal of pharmaceutical sciences and drug research

Language(s) - English

Resource type - Journals

ISSN - 0975-248X

DOI - 10.25004/ijpsdr.2017.090308

Subject(s) - gsk 3 , virtual screening , docking (animal) , glycogen synthase , computational biology , ic50 , chemistry , biochemistry , gsk3b , enzyme , kinase , binding site , combinatorial chemistry , drug discovery , stereochemistry , biology , in vitro , medicine , nursing

Glycogen synthase kinase-3? (GSK-3?) is an important class of therapeutic drug target currently receiving wide attention. In our computational approach, shape-based similarity search was used to screen the SPECS database, based on the shape of Tideglusib molecule; a known GSK-3? inhibitor. The resulting virtual hits were applied for docking studies on the known binding pockets of GSK-3?. A novel compound [7,10-dioxo-4,5-dihydro-7H,10H-pyrano[3,2,1-ij]quinolin-8-yl acetate] proposed from docking results in the substrate site of GSK-3? was found to have inhibitory activity (IC50) above 100?M concentration in ADP-GloTM Kinase assay. This communication aims to put forward in identifying newer hit on GSK-3? target via virtual screening approach.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research